Generex Biotechnology Corporation ROE

The ROE as of October 2026 (TTM) for Generex Biotechnology Corporation (GNBT) is 216.76%

According to Generex Biotechnology Corporation’s latest financial reports and current stock price. The company's current ROE is 216.76%. This represents a change of 1.90% compared to the average of 10.82% of the last 4 quarters.

Generex Biotechnology Corporation (GNBT) Historical ROE (quarterly & annually)

How has GNBT ROE performed in the past?

The mean historical ROE of Generex Biotechnology Corporation over the last ten years is 76.39%. The current 216.76% ROE has changed 183.75% with respect to the historical average. Over the past ten years (40 quarters), GNBT's ROE was at its highest in in the October 2019 quarter at 91.89%. The ROE was at its lowest in in the October 2018 quarter at -89.24%.

Generex Biotechnology Corporation (GNBT) ROE by Quarter and Year

Discovering the peaks and valleys of Generex Biotechnology Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Generex Biotechnology Corporation (GNBT) Average ROE

How has GNBT ROE performed in the past?

The current ROE of Generex Biotechnology Corporation (GNBT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Generex Biotechnology Corporation (GNBT) ROE vs. Peers

How is GNBT’s ROE compared to its peers?

Generex Biotechnology Corporation’s ROE is greater than Predictive Technology Group, Inc. (-155.36%), less than Endo International plc (60.16%), less than Clarus Therapeutics Holdings, Inc. (33.08%), greater than Propanc Biopharma, Inc. (-167.51%), greater than Nexeon MedSystems Inc. (-18.78%), less than Health-Chem Corporation (10.51%), greater than Invitae Corporation (-201.69%), greater than Aleafia Health Inc. (-58.25%), less than Humanigen, Inc. (199.39%), less than TRACON Pharmaceuticals, Inc. (90.15%),

Build a custom stock screener for Generex Biotechnology Corporation (GNBT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Generex Biotechnology Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Generex Biotechnology Corporation (GNBT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Generex Biotechnology Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.